Primary Record
FLUVASTATIN SODIUM
- In stock
- 864 g
- Purity
- 98.9 %
- CAS
- 93957-55-2
Compound Identifiers & Properties
- CAS
- 93957-55-2
- PubChem CID
- 23663976
- SMILES
- CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+]
- Canonical SMILES
- CC(C)n1c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]
Names & Synonyms
- FLUVASTATIN SODIUM
- Lescol
- Vastin
- Fluindostatin
- Fluvastatin sodium salt
- Canef
- fluvastatin
- Fractal
- Lipaxan
- Locol
- Ramnodigin
- Primesin
- Primexin
- Lymetel
- Cranoc
- Lochol
- (3R,5S)-Fluvastatin Sodium Salt
- Lescol XL
- Fluvastatin Sanabo
- Xilep XL
- Fluvastatin (sodium)
- Fluindostatin sodium
- Prestwick_1032
- 93957-55-2
- 94061-80-0
- Sri 62320
- 3R,-5S-Fluvastatin
- Fluvastatin sodium CRS
- (3r,5s)-fluvastatin sodium
- Fluyastatin Sodium Salt
- Sri-62320
- (+)-fluvastatin sodium
- C24H25FNNaO4
- Fluvastatin sodium (Lescol)
- RefChem:932147
- UNII-PYF7O1FV7F
- Fluvastatin sodium hydrate
- (Relative Stereochemistry)
- Fluvastatin sodium [USAN]
- C24H26FNO4.Na
- SCHEMBL41502
- MSK10419Na
- (3R,5S)-Fluvastatin (sodium)
- MLS001165673
- MLS001304715
- MLS006010060
- (+)-(3R,5S)-fluvastatin
- ARD193814Na
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M
- CCRIS 6848
- CHEMBL333442
- DTXSID501009854
- orb1308494
- orb2567308
- orb3025523
- DTXCID1024758
- DTXCID5065306
- DTXSID3044758
- Fluvastatin sodium [USAN:USP]
- SCHEMBL31002987
- CHEBI:77602
- Fluvastatin (sodium) (Standard)
- Fluvastatin for system suitability
- C24-H26-F-N-O4.Na
- HMS1570L19
- HMS2233N10
- HY-14664AR
- XU 62-320;Canef;Vastin;Lescol
- (+)-(3R,5S)-fluvastatin sodium
- (3R,5S)-(+)-fluvastatin sodium
- Tox21_112226
- EBC-13130
- HY-14664A
- HY-14664F
- s1909
- XU-620
- AKOS016340657
- Fluvastatin for system suitability CRS
- Tox21_112226_1
- AC-6856
- AN-6324
- CCG-264930
- CID6420065
- CS-1969
- FF23520
- KS-1062
- XU 62-320
- NCGC00164604-01
- NCGC00263525-01
- BF164477
- DA-58074
- SMR000550480
- AB2000367
- CAS-93957-55-2
- Fluvastatin sodium salt - Bio-X trade mark
- XU-62-320
- CS-0835234
- FT-0630984
- FT-0668772
- NS00076271
- ST24047218
- SW197104-2
- XU 62 -320
- H11964
- J90003
- Sodium (3R,5S,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate
- (+)-(3R,5S)-XU 62-320 (free acid)
- AB01274723-01
- EN300-7389953
- Fluvastatin Sodium Salt(Relative Stereochemistry)
- A1241227
- Q27147203
- sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate
- Sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
- Z2568666661
- (3R,5S)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
- (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
- 155229-75-7
- 93957-54-1
- (3R,5S)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt;
- (3R,5S,6E)-7-[3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL]-3,5-DIHYDROXY-6-HEPTENOIC ACID
- (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy hept-6-enoic acid sodium salt
- (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt
- (3S,5R)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt
- (e)-(3r,5s)-(+)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1h-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid sodium salt
- (e)-(3r,5s)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1h-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid sodium salt
- (e)-(3r,5s)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1h-indol-2-yl]-3,5-dihydroxy-hept-6enoic acid sodium salt
- 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))-
- Fluvastatin Sodium; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt (1:1); (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt; Canef; Cranoc; Fluindostatin; Fluvastatin sodium; Fractal; Lescol; Lescol XL; Lochol; Locol; Vastin; XU 62-320; [R*,S*-(E)]-(+/-)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt
- Sodium (+-)-(3R*,5S*,6E)-7-(3-(p-fluorophenyl)-1-isopropylindol-2-yl)-3,5-dihydroxy-6-heptenoate
- sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
- sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxyhept-6-enoate
- Sodium (E)-(3R,5S)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-hept-6-enoate
- sodium (E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate
- Sodium(3R,5S,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate
- sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate